TOCUITCONY
Trustees of Columbia University in the City of New York Portfolio holdings
AUM
$691M
This Quarter Return
-0.86%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$82.5M
AUM Growth
+$82.5M
(+10%)
Cap. Flow
+$15.4M
Cap. Flow
% of AUM
18.72%
Top 10 Holdings %
Top 10 Hldgs %
96.13%
Holding
20
New
7
Increased
–
Reduced
4
Closed
3
Top Buys
| 1 |
ACCD
Accolade, Inc. Common Stock
ACCD
|
$13.1M |
| 2 |
Sana Biotechnology
SANA
|
$9.41M |
| 3 |
Vor Biopharma
VOR
|
$7.92M |
| 4 |
CMRC
Commerce.com, Inc. Series 1 Common Stock
CMRC
|
$1.45M |
| 5 |
DoorDash
DASH
|
$923K |
Top Sells
| 1 |
Generation Bio
GBIO
|
$8.87M |
| 2 |
Kymera Therapeutics
KYMR
|
$5.84M |
| 3 |
Seres Therapeutics
MCRB
|
$1.47M |
| 4 |
Progyny
PGNY
|
$685K |
| 5 |
Asana
ASAN
|
$504K |
Sector Composition
| 1 | Healthcare | 41.18% |
| 2 | Financials | 36.81% |
| 3 | Industrials | 15.89% |
| 4 | Technology | 4.37% |
| 5 | Consumer Discretionary | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.09T
| $30.1M | 36.46% |
78
| – | – |
|
|
ACCD
2
DELISTED
Accolade, Inc. Common Stock
ACCD
| $13.1M | 15.89% |
+288,892
| New | +$13.1M |
|
|
3
Kymera Therapeutics
KYMR
$2.95B
| $12.2M | 14.75% |
313,127
-150,171
| -32% | -$5.84M |
|
|
4
Sana Biotechnology
SANA
$777M
| $9.41M | 11.41% |
+281,250
| New | +$9.41M |
|
|
5
Vor Biopharma
VOR
$250M
| $7.92M | 9.6% |
+183,821
| New | +$7.92M |
|
6
RAPT Therapeutics
RAPT
$188M
| $1.63M | 1.97% |
73,383
| – | – |
|
|
CMRC
7
Commerce.com, Inc. Series 1 Common Stock
CMRC
$375M
| $1.45M | 1.76% |
+25,065
| New | +$1.45M |
|
|
EVLO
8
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $1.22M | 1.48% |
113,850
| – | – |
|
|
KLDO
9
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $1.22M | 1.47% |
150,150
| – | – |
|
10
Microsoft
MSFT
$3.77T
| $1.1M | 1.34% |
4,678
| – | – |
|
|
11
DoorDash
DASH
$105B
| $923K | 1.12% |
+7,040
| New | +$923K |
|
|
12
Asana
ASAN
$3.44B
| $581K | 0.7% |
20,327
-17,643
| -46% | -$504K |
|
13
Twilio
TWLO
$16.2B
| $470K | 0.57% |
1,380
-1,315
| -49% | -$448K |
|
14
Antero Resources
AR
$9.86B
| $425K | 0.52% |
+41,633
| New | +$425K |
|
|
15
Progyny
PGNY
$2.04B
| $411K | 0.5% |
9,224
-15,373
| -62% | -$685K |
|
|
16
Berkshire Hathaway Class B
BRK.B
$1.09T
| $282K | 0.34% |
1,100
| – | – |
|
17
Antero Midstream
AM
$8.51B
| $101K | 0.12% |
+11,130
| New | +$101K |
|
|
18
Generation Bio
GBIO
$40.4M
| – | – |
-312,876
| Closed | -$8.87M |
|
|
19
Seres Therapeutics
MCRB
$166M
| – | – |
-59,930
| Closed | -$1.47M |
|
20
Ribbon Communications
RBBN
$722M
| – | – |
-13,085
| Closed | -$86K |
|